HC Wainwright & Co. Downgrades Silverback Therapeutics to Neutral

HC Wainwright & Co. analyst Edward White downgrades Silverback Therapeutics (NASDAQ:SBTX) from Buy to Neutral.

HC Wainwright & Co. analyst Edward White downgrades Silverback Therapeutics (NASDAQ:SBTX) from Buy to Neutral.

Total
0
Shares
Related Posts